Naphthohydroquinone Dehydrogenase in Human Saliva
スポンサーリンク
概要
- 論文の詳細を見る
A semisynthetic antibiotic rifampicin 3-(4-methyl-piperazinyl-iminomethyl)-rifamycin SV has been noted clinically as a powerful antibacterial drug. But of metabolism of the drug in human body, many problems still remain unknown. A remarkable experimental fact was found that rifampicin was promptly oxidized by treating with human saliva under hydrochloric acid condition. As such oxidation could not be observed in the solution of this acid without saliva, it seemed that a certain enzyme should bring about this oxidation. This is a report about a special oxidation enzyme present in human saliva.<BR>By using rifampicin as a substrate, the salivary enzyme activity could be determined tentatively by a spectrophotometric assay in accordance with the principle that by oxidation of rifampicin the absorption peak is changed from 475 mμ to 540mμ. This enzyme was relatively unstable, being destroyed gradually at 25° However, when stored at 5°, it was possible to keep the enzyme in constant activity for a long time. The enzyme activity was completely inhibited by H<SUB>2</SUB>S, cysteine, cyanides, citrates and diethyldithiocarbamate. This is an evidence to show that this enzyme contains a certain heavy metal, perhaps copper which is a conspicuous oxidation catalyst. Methanol, ethanol and propanol were also very strong inhibitors, and it was further observed that pig's pancreatic lipase attacked strongly the activated enzyme under acid condition. These inactivations probably suggest that the enzyme also contains some lipid which is required perhaps for the complete activity.<BR>With rifampicin as a substrate, the complete enzyme activity appeared at a very low pH below 3. In contrast, no activity was observed at a pH over 4. Narrowness of the pH range susceptible to convert the enzyme from inactivity into activity was also remarkable. Such pH dependent activity of this enzyme indicates undoubtedly that the original enzyme in saliva is in an inactive form, and is activated by gastric acid (HCl) when reached the stomach. The salivary enzyme at a neutral pH revealed a complete resistance to heat treatments within 30 minutes. But the activated enzyme in acid saliva was very unstable, so that the enzyme was inactivated rapidly and completely at 40° for 30 minutes, and partially at 37°. In addition, any mechanical treatments seemed to constitute hindrance to the activated enzyme.<BR>When saliva was dialyzed in a cellophane bag against distilled water for one day at 5°, the enzyme activity was recognized in the liquid outside of cellophane bag. The enzyme was eluted in a localized manner in a peptide fraction when saliva had been gel-filtrated with distilled water on a 1.4×15cm Sephadex G-15 column. The enzyme fraction appeared to be of positive ninhydrine reaction and of negative biuret reaction. It may thus be concluded that this enzyme is a very low molecule compound, perhaps consisting of oligopeptide.<BR>A heavy metal, which forms a black metal sulfide by reaction with ammonium sulfide, was detectable apparently in the enzyme fraction while negligible in other fractions. But Cl and urea exerting any questionable influence on the enzyme activity were both negative in the fraction. Paper chromatography of a relatively pure enzyme fraction obtained by gel-filtration revealed only one spot, which was coloured by spray of ninhydrine. However, there have remained further demonstrations to prove that the spot is identical to the enzyme itself.<BR>The specific absorption peak of the enzyme fraction was found around 270mμ. This enzyme was distinguishable from well-known copper enzymes: tyrosinase, ascorbase and polyphenol oxidase, and also peroxidase which is a porphyrin iron compound, in view of comparison of their optimum pH, molecular weight and spectrum one with another.
- Japan Society of Clinical Chemistryの論文
著者
関連論文
- 呼吸器病学を中心に (〔最新医学〕500号記念座談会--戦後40余年--医学の進歩を語る)
- F-72. ブレオマイシンによる肺癌の治療 : 治療 V
- Rifampicinの高desacetylationと副作用について
- 肺癌患者における血清α-リポ蛋白値と肺の組織リパーゼ活性について
- 1.臨床試験の科学性と倫理性(リハビリテーションにおける効果判定)
- 臨床医学研究法序説
- 大村潤四郎さんを悼む
- 治療効果の考え方 : とくにRh医学に関連して
- リハビリテーション医学理念の形成と成熟
- 人間世界の出来事としての安全性問題(医薬品の安全性を考える)
- 3.医療薬学教育に何を求めるか : 1)臨床医の立場から(医療薬学教育はどうあるべきか)
- 障害論の100年 : 森鴎外からICIDHまで
- 二木 立・上田 敏著世界のリハビリテーション(A5判, 230頁 定価4,500円 300 1980年医歯薬出版) : リハビリテーションと障害者福祉の国際比較
- 医療の中の薬 : 医療チームの中の薬剤師
- 「目でみるリハビリテーション医学」 東大リハビリテーション部 上田敏著(A4変形, 80ページ, 2200円, 東大出版会)
- 私達の眼の前にあるもの
- リハビリテーション医療の新しい展開と理学療法士
- 生命の質と医療の質
- 薬効再評価--それは臨床家にとって何を意味するか (薬物療法の実際)
- リハビリテ-ションのための統計学-1-統計の考え方,統計的な考え方
- リハビリテ-ション医学理念の成立--歴史的回顧 (リハビリテ-ションの歴史)
- Rifampicinの高desacetylationと副作用について
- 肺結核の短期化学療法の評価 (第1報) : 国療化研第19次・20次A研究
- I. 結核の研究と診療における倫理
- 老人の結核
- Rifampicinの人体内代謝 (第1報)
- サルのINH代謝型
- 遊離INHの新化学的定量法によるINH代謝の研究(第2報)
- Free INHの新定量法によるINH代謝の研究(第1報)
- Naphthohydroquinone Dehydrogenase in Human Saliva
- Rifampicin Oxidation Catalyst in Human Saliva
- タイトル無し